Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Leukemia Research|January 1, 1991
Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cellsM Makishima, Y Honma, M Hozumi, et al.
Cancer Research|December 15, 1987
Chromosome abnormalities in malignant lymphoma in patients from SaitamaN Maseki, Y Kaneko, M Sakurai, et al.
Experimental Hematology|July 1, 1993
Differentiation of human myeloblastic leukemia ML-1 cells into macrophages by staurosporine, an inhibitor of protein kinase activitiesM Makishima, Y Honma, M Hozumi, et al.
Gan|June 1, 1984
Differentiation in vitro of human myelogenous leukemia cells from patients in relapseY Honma, Y Fujita, T Kasukabe, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1983
Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60Y Honma, Y Fujita, T Kasukabe, et al.
Experimental Hematology|August 1, 1992
Effects of novel uracil analogs on proliferation and differentiation of human myeloid leukemia cellsM Makishima, Y Honma, M Hozumi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1992
[Malignant lymphoma occurring subsequent to autoimmune disease]T Matsunaga, N Maseki, Y Kaneko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1984
[Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma]S Akazawa, H Kitagawa, T Nakagawa, et al.
International Journal of Hematology|August 14, 1999
A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study GroupY Takemoto, K Sampi, Y Kuraishi, et al.
The Japanese Journal of Antibiotics|August 1, 1994
[Empiric therapy with fluconazole in granulocytopenic patients with carcinoma or leukemia]M Fukuda, K Hirashima, R Kurane, et al.
Pageof 8